- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
1997–2026 · program · P30
Survey and Qualitative Methods Core
Wendy Beth London · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 35: Melanoma
Frank S Hodi · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Shared Resource 07: Medicinal Chemistry
Nathanael Schiander Gray · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Tumor Imaging Metrics Core
Gordon J Harris · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Shared Resource 08: Pathology Specimen Locator
Frank C Kuo · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Biostatistics Core
Paul J Catalano · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Community Outreach and Engagement
Timothy R Rebbeck · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 11 Cancer Immunology
Kai W Wucherpfennig · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 52: Kidney Cancer
David Mcdermott · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Shared Resource 15: Biostatistics
Paul J Catalano · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P01
Biology and therapeutic targeting of zinc finger transcription factors in AML
Scott A Armstrong · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 04 Leukemia
Andrew A Lane · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 07 Cancer Epidemiology
A. Heather Eliassen · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 30: Neuro-Oncology
Tracy T Batchelor · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Leadership, Planning, and Evaluation
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Planning and Evaluation
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 34: Lung Cancer
Bruce E. Johnson · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 4: Leukemia
David Marc Weinstock · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Shared Resource 06: DNA Resource
Stephanie E Mohr · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Developmental Funds
Peter M Howley · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Clinical Protocol and Data Management
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Shared Resource 11: Tissue Microarray and Imaging
Sabina Signoretti · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 30: Neuro-Oncology
Tracy T Batchelor · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2030 · program · P01
Molecular basis for microtubule-destabilization dependent MYB degradation
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Administrative Core
Drew Memmott · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 52: Kidney Cancer
Toni Choueiri · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Administrative Core
Deborah J Goff · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Research Pharmacy Core
Sylvia Bartel · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P01
Administrative Core
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 32: Gastrointestinal Malignancies
Adam Joel Bass · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 9: Cancer Genetics
David J. Kwiatkowski · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Protocol Review and Monitoring System
Jeffrey A Meyerhardt · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 01 Breast Cancer
Sara M. Tolaney · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 10: Cancer Care Delivery Research
Deborah Schrag · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Cell Manipulation Core Facility
Jerome Ritz · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 07 Cancer Epidemiology
Lorelei Mucci · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2030 · program · P01
Biostatistics and Computational Biology
Jeremy M. Simon · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2030 · program · P01
Defining mechanisms of action of Menin inhibition in AML
Scott A Armstrong · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Population Sciences Laboratory Core
Immaculata De Vivo · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 30: Neuro-Oncology
Tracy T Batchelor · Dana-Farber Cancer Institute · funded by National Institutes of Health
